Detailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.
There has been a swing towards in vivo CAR-T therapies lately, as big pharmas sign acquisition deals and new therapies hit ...
The biggest bargain in big pharma? Probably the best argument against Bristol Myers Squibb being the biggest bargain in big ...
Bristol-Myers Squibb Company (NYSE:BMY) remains a favorite for conservative portfolios due to its exceptionally low ...
In this article, we will list the 5 best defensive stocks to invest in now.
I love the people I work with.” At the same time, Squibb allows that she has stopped saying yes to every project that crosses ...
Bristol-Myers Squibb is deeply undervalued at 8.9x forward earnings due to overblown patent cliff fears on Eliquis and Opdivo. The Growth Portfolio now generates 55% of revenue, grew 17% in FY2025, ...
Cam Sample, a defensive end for the Cincinnati Bengals since 2021, agreed to a one-year deal with the San Francisco 49ers, according to a report via Twitter/X from NFL Network's Tom Pelissero. Sample, ...
EXCLUSIVE: Bristol Myers Squibb is launching three medications on TrumpRx.gov on Monday, FOX Business has learned. The three prescription drugs will each be offered at deep discounts that range from ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. You shall have music wherever you go. The new MPC Sample is a fully portable devices for ...
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced positive interim Phase 3 results from the SUCCESSOR-2 study (NCT05552976). In the trial, oral mezigdomide in ...
The company's "growth portfolio" is offsetting declines in "legacy" treatments. It also showed marked progress in two of its developmental programs. Near the start of February, Bristol Myers Squibb ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results